Biomarker Assay Development and Validation: Ensuring Reliability in Clinical Applications
Biomarkers have become essential tools in modern medicine, providing critical insights into disease states, treatment efficacy, and...
top of page
Jul 10
Harnessing Bioconjugation for Therapeutic Advancements
In modern medicine, the field of bioconjugation has emerged as a powerful tool for advancing therapeutic applications. By combining...
Jul 3
Navigating the Sensitivity vs. Specificity Dilemma in In Vitro Diagnostics
In vitro diagnostics (IVD) are pivotal tools in healthcare, aiding in disease diagnosis, monitoring, and treatment decisions. However,...
Jun 11
Quality Control in Immunoassay Development to Ensure Reliable Results
In the realm of biomedical research and clinical diagnostics, immunoassays play a pivotal role in detecting and quantifying biomolecules...
May 17
Scope Creep from IVDR into Regulated Bioanalysis
As industries evolve, so do regulations governing them. The In Vitro Diagnostic Regulation (IVDR) was introduced to enhance the safety...
Apr 23
Navigating Challenges in the Development of ADA Assays for Immunogenicity Studies
In the realm of biopharmaceutical development, understanding and mitigating the immunogenicity of therapeutic proteins is crucial for...
Apr 5
Choosing the Right Platform for ADA Assays in Immunogenicity Studies: A Critical Decision
In the realm of biopharmaceutical development, understanding and mitigating the immunogenicity of therapeutic proteins is paramount....
Feb 26
Streamlining Success: The Compelling Reasons to Outsource Bioconjugation and Antibody Labelling
In the dynamic landscape of life sciences and diagnostics, bioconjugation and antibody labelling stand as critical processes in advancing...
Jan 31
Unlocking Efficiency: Reasons to Outsource Immunoassay and ELISA Development
In the rapidly evolving landscape of life sciences and diagnostics, immunoassays and ELISAs play a pivotal role in detecting and...
Jan 8
The Crucial Role of ISO 13485 Accreditation in Elevating In Vitro Diagnostic Development
Introduction: In the realm of medical devices, particularly in vitro diagnostics (IVD), ensuring the highest standards of quality,...
Dec 6, 2023
The Importance of Expert Witness Testimony
Recently, one of Fleet Bioprocessing’s experts was asked to consult on a project. Nothing unusual about that, Fleet experts regularly act...
Dec 1, 2023
Antibody-Drug Conjugates and the Imperative for Reproducible Conjugation Methods
One of the most notable recent innovations in the field of medical science is the development of Antibody-Drug Conjugates (ADCs). ADCs...
Nov 21, 2023
Your Premier Partner for Gyrolab Assay Reagents
At Fleet Bioprocessing Ltd., we take pride in being a Gyrolab Certified Assay Transfer and Development Partner. Fleet Bioprocessing Ltd....
Sep 11, 2023
The Role of Education at Fleet Bioprocessing
At Fleet Bioprocessing we believe in the power of education and its role in shaping the next generation of talented scientists. Through...
Jul 25, 2023
8 critical tips to consider when developing and optimising an immunoassay or ELISA.
Optimising an ELISA method involves several steps to enhance the accuracy, sensitivity, specificity, and overall performance of the...
Mar 27, 2023
Fleet contribute to Structure-Function Metrology of Proteins
Fleet Bioprocessing Ltd collaborated the National Physical Laboratory and the National Measurement Laboratory (at LGC Ltd) on a project...
Feb 14, 2023
Critical reagents for ligand binding assays
Ligand binding assays (LBAs) are commonly used in the pharmaceutical industry to determine the potency and specificity of drug...
Nov 22, 2022
Publication in Organic and Biomolecular Chemistry
Fleet Bioprocessing's Director of Chemistry, Chris Blencowe, contributes to " Exploring the versatility of pentafulvene–maleimide...
Jun 1, 2019
June 2019: Two Posters from Analysis for Innovators Project Presented at International Meetings.
Two posters are being presented from Fleet Bioprocessing Ltd.’s recent Innovate UK-funded collaboration with LGC Ltd. and the National...
bottom of page